It’s one small step forward for Vascular Biogenics (VBLT), one giant leap for the company’s stock rating. H.
H.C.
Shares of Vascular Biogenics Ltd (NASDAQ:VBLT) slumped on Friday, falling 18% as of 10:30 a.m.
Roth Capital analyst Joseph Pantginis weighed in with a few insights on Vascular Biogenics Ltd (NASDAQ:VBLT), after the Israeli biotech company presented updated data from its Phase …
Oppenheimer analyst Yigal Nochomovitz initiated an Outperform rating on Vascular Biogenics (NASDAQ:VBLT) with a $16 price target, which implies an upside of 144% from current levels. Nochomovitz …
